Presbyopia may affect more than 1 billion worldwide
Cancer patients, with their weakened immune systems, are particularly vulnerable when the cold and flu season hits. The National Cancer Institute (NCI), part of the National Institutes of Health and the world’s most prestigious cancer research body, is sponsoring a landmark trial to evaluate if a unique Canadian cold remedy - ginseng extract COLD-FX -
Full Post: NCI sponsors Canadian cold/flu remedy trial in leukemia patients
It is estimated that more than 1 billion individuals worldwide in 2005 had presbyopia, or age-related difficulty in seeing objects nearby, with an estimated 410 million with the condition unable to perform tasks requiring near vision, according to a report in the December issue of Archives of Ophthalmology.
Presbyopia occurs with age, as the eye’s lens loses its elasticity and ability to focus on close objects, according to background information in the article. “Although known physiology and population demographics suggest that presbyopia is common or nearly universal in people older than 65 years, direct estimates of prevalence are rare,” the authors write. “The total number of people with presbyopia is primarily of interest as a precursor to the figures of greatest public health interest: the number of people with impaired vision due to uncorrected or undercorrected presbyopia and the effect on their lives.”
Brien A. Holden, Ph.D., D.Sc., of the University of New South Wales, Sydney, Australia, and colleagues analyzed multiple surveys to estimate the global prevalence of presbyopia, along with the rate at which the condition is corrected and the vision impairment caused when it is not. They then used the International Data Base of the U.S. Census Bureau to extrapolate estimates for the future.
Using projections from these surveys, the researchers estimate that 1.04 billion people globally had presbyopia in 2005, 517 million of whom had no eyeglasses or inadequate eyeglasses or spectacles. Most (386 million, or 94 percent) of the individuals whose daily tasks were impaired by uncorrected presbyopia lived in the developing world.
These estimates are based on the best available information, the authors note. “More epidemiological research in presbyopia is needed to decrease the assumptions and generalizations required for a better global estimate,” the authors write. “As more data become available, an increasingly accurate picture of the burden of presbyopia will emerge.”
The researchers predict that the worldwide prevalence of presbyopia will increase to 1.4 billion by 2020 and 1.8 billion by 2050. “Without intervention to make spectacles more accessible, the global number of individuals who will have a disability associated with uncorrected presbyopia is predicted to grow to 563 million people by 2020,” the authors conclude. “If the goal of Vision 2020 to eliminate unnecessary blindness and impaired vision, in this case due to uncorrected refractive error, is to be achieved, planning will have to include the provision of human resources, affordable spectacles and systems of delivery for these half-billion people in need.”
Based on projected increases in the prevalence of diabetes, the number of people with diabetes-related retinal disease, with glaucoma and with cataracts is estimated to increase significantly by 2050, according to a report in the December issue of Archives of Ophthalmology. Diabetic retinopathy (damage to the small blood vessels in the retina) is the leading
Full Post: Cases of major eye disease projected to increase among diabetics
Household budget cutbacks are becoming commonplace as most Americans struggle to make ends meet, but experts warn that health care needs should not be among the forfeited services. Recent research indicates that more than 20 percent of people have cut back on medical visits to save money and The Vision Council warns that this cost-saving
Full Post: Household budget cutbacks in health care could have serious consequences
Abbott and Advanced Medical Optics (AMO) have announced a definitive agreement for Abbott to acquire AMO for $22 per share in cash, for a total transaction value of approximately $2.8 billion, inclusive of estimated net debt at the time of closing. Based in Santa Ana, Calif., AMO is a global leader in ophthalmic care, comprised
Full Post: Abbott to acquire Advanced Medical Optics
A study in the Jan. 1 issue of the journal Sleep indicates that the indirect costs of untreated insomnia are significantly greater than the direct costs associated with its treatment. The study estimates that the total annual cost of insomnia in the province of Quebec is 6.5 billion Canadian dollars, representing about one percent of
Full Post: Social and economic burden of insomnia is high
A newly developed equation produces more accurate estimates of the glomerular filtration rate (GFR) - a key indicator of kidney function in patients with chronic kidney disease (CKD), according to research being presented at the American Society of Nephrology’s 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania. “Equations to estimate GFR are routinely used
Full Post: New equation provides more accurate estimates of the glomerular filtration rate